Berdagang Amgen AMGN

Amgen carta live

Asas Instrumen

Weekly Search
Weekly
Daily
Tarikh Tutup Perubahan Perubahan (%): Buka Tinggi Rendah

Amgen news

Frances Wang 2024 Nov 26, 16:00

Stock Market Today: S&P 500 and Dow Reach New High On Trump’s Tariff Policy

Stocks
Frances Wang 2024 Aug 04, 16:00

The Week Ahead: ISM services, SMCI

CFD Trading
Australian dollar shrugs at RBA decision to keep interest rates unchanged
Georgy Istigechev 2024 Aug 03, 21:00

Week ahead: RBA meeting, Uber earnings, and PMIs

CFD Trading Forex
Disney is catching up with Netflix
Neil Wilson 2024 Feb 01, 08:03

Week ahead: Earnings season climax

Forex Indices
Bank of England BoE
Neil Wilson 2023 Oct 27, 10:00

Week ahead: Fed, Bank of England seen on pause; Apple earnings

Forex Indices

Berita Terkini

Tunjukkan lebih lagi
Australia CPI
Tommy Yap 2025 Mei 24, 21:00

Week Ahead: Canada, U.K. and Japan’s Inflation Data in Spotlight

Forex Indices
Tommy Yap 2025 Mei 22, 16:00

Morning Note: Japan's Core Inflation Spikes; UK Retail Surges; Canada Sales Slow

Morning Note
Frances Wang 2025 Mei 21, 16:00

What is the TQQQ ETF: What are the risks associated with TQQQ ETF?

ETFs
Tommy Yap 2025 Mei 21, 16:00

Morning Note: Nvidia Slams China Chip Ban; Bitcoin Climbs on Trade Peace;

Morning Note Tech Cryptocurrencies
Tommy Yap 2025 Mei 21, 16:00

Morning Note: UK Inflation Surprises Higher; Mideast Tensions Fuel Oil, Gold

Morning Note Commodities
Frances Wang 2025 Mei 20, 16:00

Palantir Stock Price Analysis: What is the prediction for PLTR?

Stocks
Frances Wang 2025 Mei 19, 16:00

Stock index news today: ASX 200 goes higher on RBA Rate Cut

Indices
Tommy Yap 2025 Mei 19, 16:00

Morning Note: RBA Eases Policy; Canada's Inflation Outlook; China Lowers Rates

Morning Note AUD CAD China

Maklumat

Sebaran nilai

1.85

Spread (%)

0.6824 %

Leveraj

1:10

Faedah semalaman (Beli)

-0.0597 %

Faedah semalaman (Jual)

-0.0292 %

Mata wang

USD

Waktu perdagangan

Pasaran ditutup

Selasa

13:31 - 19:59

Rabu

13:31-19:59

Khamis

13:31-19:59

Jumaat

13:31-19:59

Analisis dan statistik

Buka

---

Tutup Terdahulu

---

Tinggi/Rendah 52 Minggu

--- – ---

Modal pasaran

146073206784

Saham Tertunggak

537705984

Tarikh Pendapatan (Seterusnya)

1999-11-22

Hasil Div

2025-06-06

Tarikh Selepas Dividen

2025-05-16

Kadar dividen tahunan depan

9.52

Hasil dividen tahunan depan

0.035

EPS

10.98

Ketahui lebih lanjut mengenai instrumen ini

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

latest_education_articles

Tunjukkan lebih lagi
Trustpilot